Great Point Partners

Great Point Partners is a Greenwich, Connecticut-based specialized healthcare investment firm funding the rapid expansion of life sciences tools and pharmaceutical service companies. The firm’s focus is squarely on Life Sciences Tools and Pharma/Therapeutics service providers, not consumer health or care delivery software. AI is not a dedicated thesis, and limited specific AUM information appears in the source data.

Check sizes are $5M-$25M at the growth stage, suitable for minority growth or smaller control investments. Geographic deployment is primarily U.S., with focus on companies serving the biopharma and life sciences value chain. Specific portfolio companies are not listed in the source data. Founders engaging with Great Point should expect deep diligence on customer concentration with biopharma sponsors, regulatory risk, and the durability of contracted revenue.

This is a niche fit, not a default destination. Founders should approach Great Point only if they are running a CRO, CDMO, lab services, or life sciences tools business with established commercial traction. Physician AI builders working in clinical workflow are unlikely to be a match. The right profile is a life sciences services CEO with several million dollars of EBITDA and a clear roadmap for growth or roll-up.